Therapeutic Asset Ratings
374 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
[177lu]lu-nns309
Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
225ac-etn029
Gastroenteropancreatic Neuroendocrine Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
225ac-etn029
Pulmonary Large Cell Neuroendocrine Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
225ac-etn029
Prostate Neuroendocrine Neoplasm
Novartis Pharmaceuticals
P1
CC
(43)
2-OXAZOLIDINONE, 4-((1S)-1-FLUOROETHYL)-3-(2-(((1S)-1-(4-METHYL-2'-(TRIFLUOROMETHYL)(3,4'-BIPYRIDIN)-6-YL)ETHYL)AMINO)-4-PYRIMIDINYL)-, (4R)-
Advanced Malignancies That Harbor IDHR132 Mutations
Novartis Pharmaceuticals
P1
CC
(43)
68ga-dfc413
Invasive Ductal Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68ga-dfc413
Invasive Lobular Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68ga-dfc413
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68ga-dfc413
Soft Tissue Sarcoma
Novartis Pharmaceuticals
P1
CC
(43)
[68ga]ga-dwj155
Gastroesophageal Cancer
Novartis Pharmaceuticals
P1
CC
(43)
[68Ga]Ga-NNS309
Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68Ga-NNS309
Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68Ga-NNS309
Invasive Ductal Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68Ga-NNS309
Invasive Lobular Breast Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
68Ga-NNS309
Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals
P1
CC
(43)
ARG
Metastatic Neuroendocrine Prostate Cancer
Novartis Pharmaceuticals
P1
CC
(43)
dff332
Renal Cell Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
dky709
Colorectal Cancer
Novartis Pharmaceuticals
P1
CC
(43)
DOTA-PABZA-DIG-DPHE-GLN-TRP-ALA-VAL-GLY-HIS-NHCH(CH2CH(CH3)2)2
Prostate Neuroendocrine Neoplasm
Novartis Pharmaceuticals
P1
CC
(43)
DOTA-PABZA-DIG-DPHE-GLN-TRP-ALA-VAL-GLY-HIS-NHCH(CH2CH(CH3)2)2
Glioblastoma
Novartis Pharmaceuticals
P1
CC
(43)
Epirubicin
Carcinoma, Thymic
Novartis Pharmaceuticals
P1
CC
(43)
hro761
Cancer
Novartis Pharmaceuticals
P1
CC
(43)
kfa115
Ovarian Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
kfa115
Renal Cell Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
kfa115
Thymic Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
Showing 226 to 250 of 374 assets
Previous
Page 10 of 15
Next
